Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clostridium difficile colitis and diarrhea

C Pothoulakis1, J T LaMont

  • 1Section of Gastroenterology, Boston University School of Medicine, University Hospital, MA 02118.

Gastroenterology Clinics of North America
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome.

Neurogastroenterology and motility·2015
Same author

Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.

Mucosal immunology·2014
Same author

Unexpected discovery of massive liver echinococcosis. A clinical, morphological, and functional diagnosis.

Annals of hepatology·2013
Same author

[Recent advances in Saccharomyces boulardii research].

Gastroenterologie clinique et biologique·2010
Same author

Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii.

Alimentary pharmacology & therapeutics·2009
Same author

Melanin-concentrating hormone (MCH) modulates C difficile toxin A-mediated enteritis in mice.

Gut·2008
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Clostridium difficile infection (CDI) is a common hospital-acquired infection caused by C. difficile. While treatable, CDI frequently relapses, requiring further antibiotic courses.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Gastroenterology

Background:

  • Clostridium difficile is a leading cause of hospital-acquired infections.
  • Antibiotic use disrupts gut flora, facilitating C. difficile colonization.
  • C. difficile produces toxins causing colitis and diarrhea.

Purpose of the Study:

  • To summarize the epidemiology, pathophysiology, and treatment of Clostridium difficile infections.
  • To highlight the challenge of recurrent C. difficile infections.

Main Methods:

  • Literature review of Clostridium difficile infection.
  • Analysis of disease mechanisms and host responses.
  • Evaluation of current therapeutic strategies and relapse rates.

Related Experiment Videos

Main Results:

  • Clostridium difficile infects up to 25% of hospitalized patients.
  • Infection spectrum ranges from asymptomatic to severe pseudomembranous colitis.
  • 15-20% of patients experience relapses after initial therapy.

Conclusions:

  • Effective treatments like vancomycin and metronidazole exist for C. difficile.
  • Recurrent C. difficile infections pose a significant clinical challenge.
  • Multiple treatment courses may be needed for persistent or relapsing cases.